UNII OJ245FE5EU

SODIUM BENZOATE

Unique Ingredient Identifier OJ245FE5EU is listed as a ingredient substance
UniiOJ245FE5EU
Preferred Substance NameSODIUM BENZOATE
Rn532-32-1
Ec208-534-8
NcitC66541
Rxcui56455
Pubchem517055
Molecular FormulaC7H5O2.Na
InchikeyWXMKPNITSTVMEF-UHFFFAOYSA-M
Smiles[Na+].[O-]C(=O)C1=CC=CC=C1
Unii TypeINGREDIENT SUBSTANCE
RN532-32-1
EC208-534-8
NCITC66541
RXCUI56455
PUBCHEM517055
MFC7H5O2.Na
INCHI KEYWXMKPNITSTVMEF-UHFFFAOYSA-M
SMILES[Na+].[O-]C(=O)C1=CC=CC=C1

Alternate Names

Dosage Forms

UNII OJ245FE5EU SODIUM BENZOATE is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALFILM0.96 MG
BUCCALFILM, SOLUBLE0.69 MG
DENTALGEL0.08 %
DENTALPASTE0.08 %
IM - IVINJECTION10 %
INTRAMUSCULARINJECTION5 %
INTRAMUSCULARSOLUTION, INJECTION4.8 %W/V
INTRAVENOUSEMULSION, INJECTION0.1 %
INTRAVENOUSINJECTABLE0.07 %
IV(INFUSION)INJECTION5 %
ORALCAPSULE0.3 MG
ORALCAPSULE, HARD GELATIN0.11 MG
ORALCONCENTRATE2 MG/1ML
ORALDROPS3 MG/1ML
ORALEMULSION NA
ORALFOR SUSPENSION10 MG/5ML
ORALGRANULE, FOR RECONSTITUTION10 MG
ORALGRANULE, FOR SUSPENSION10 MG
ORALLIQUID10.13 mg/10mL
ORALLIQUID1 MG/1ML
ORALLIQUID,EXTENDED RELEASE2 MG/ML
ORALORAL SOLUTION DOSAGE FORM2.5 mg/5mL
ORALPOWDER0.01 MG
ORALPOWDER, FOR ORAL SOLUTION98 MG
ORALPOWDER, FOR ORAL SUSPENSION20 MG/5ML
ORALPOWDER, FOR RECONSTITUTION5 MG/5ML
ORALPOWDER, FOR SOLUTION93.32 MG/5ML
ORALPOWDER, FOR SUSPENSION20 MG/1ML
ORALSOLUTION90 MG/160ML
ORALSOLUTION15 MG/5ML
ORALSOLUTION, ELIXIR5.02 MG/5ML
ORALSOLUTION, LIQUID1 MG/1ML
ORALSOLUTION, SYRUP5 MG/5ML
ORALSUSPENSION10 MG/5ML
ORALSUSPENSION2.5 mg/1.25mL
ORALSUSPENSION, DROPS2.5 MG/1ML
ORALSUSPENSION, LIQUID10 MG/5ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION0.05 %
ORALSYRUP10 MG/1ML
ORALTABLET5 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESC60 MG
ORALTABLET, COATED9 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED0.34 MG
ORALTABLET, FILM COATED0.02 MG
ORALTABLET, SUSTAINED ACTION NA
RECTALENEMA0.1 %
RECTALGEL2.54 %
RECTALSUPPOSITORY NA
TOPICALEMULSION NA
TOPICALEMULSION, CREAM0.2 %W/W
TOPICALEMULSION, CREAM0.2 %W/W
TOPICALGEL0.24 %W/W
TOPICALPATCH NA
TOPICALSOLUTION0.1 %W/V
TOPICALSPONGE NA

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.